Загрузка...
A Case of De Novo Psoriasis Secondary to Nivolumab in a Patient With Metastatic Renal Cell Carcinoma
Immune-mediated adverse events are commonly seen with immune checkpoint inhibitors like nivolumab. Oncology specialists usually have to screen patients for risk factors for autoimmune diseases, since immune checkpoint inhibitors can potentially exacerbate these events. Some of the immune-mediated si...
Сохранить в:
| Опубликовано в: : | Cureus |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cureus
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8288591/ https://ncbi.nlm.nih.gov/pubmed/34290912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.15703 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|